Literature DB >> 9870930

5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils.

W S Powell1, S Gravel, F Halwani.   

Abstract

5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) is a metabolite of arachidonic acid formed by the oxidation of 5-hydroxy-6,8,11, 14-eicosatetraenoic acid by a highly specific dehydrogenase. 5-oxo-ETE is a chemoattractant for both neutrophils and eosinophils. Although it is not as effective as leukotriene B4 (LTB4) and platelet-activating factor (PAF) in stimulating neutrophil migration, we found that it is considerably more active than these and a variety of other lipid mediators as an eosinophil chemoattractant. Moreover, low concentrations of 5-oxo-ETE appear to enhance the responsiveness of these cells to PAF. The objectives of the current investigation were to identify rapid responses induced in eosinophils by 5-oxo-ETE that might be related to the infiltration of these cells into tissues. We found that 5-oxo-ETE is more effective than PAF and LTB4 in inducing both L-selectin shedding and actin polymerization in human eosinophils, whereas PAF is the most active of these mediators in stimulating calcium mobilization. The complementary effects of 5-oxo-ETE and PAF on actin polymerization and calcium mobilization may explain their synergistic effect on eosinophil migration. 5-oxo-ETE and PAF were equipotent in stimulating the surface expression of the beta2-integrin CD11b, but were slightly less potent than LTB4. 5-oxo-ETE- induced actin polymerization was subject to homologous but not heterologous desensitization. It was not prevented by incubation of eosinophils with inhibitors of protein kinase C (staurosporine), mitogen-activated protein kinase kinase (PD98059), or phosphatidylinositol-3-kinase (wortmannin). In conclusion, 5-oxo-ETE is a potent activator of human eosinophils and may be an important regulator of tissue infiltration of these cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9870930     DOI: 10.1165/ajrcmb.20.1.3141

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  12 in total

1.  Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes.

Authors:  Chantal Cossette; Sylvie Gravel; Chintam Nagendra Reddy; Vivek Gore; Shishir Chourey; Qiuji Ye; Nathaniel W Snyder; Clementina A Mesaros; Ian A Blair; Jean-Pierre Lavoie; Carol R Reinero; Joshua Rokach; William S Powell
Journal:  Biochem Pharmacol       Date:  2015-05-29       Impact factor: 5.858

Review 2.  The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.

Authors:  William S Powell; Joshua Rokach
Journal:  Prog Lipid Res       Date:  2013-09-19       Impact factor: 16.195

3.  'Outside-in' signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils.

Authors:  O T Lynch; M A Giembycz; P J Barnes; P G Hellewell; M A Lindsay
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

4.  C20-trifluoro-5-oxo-ETE: a metabolically stable 5-oxo-ETE derivative.

Authors:  Pranav Patel; Vivek Gore; William S Powell; Joshua Rokach
Journal:  Bioorg Med Chem Lett       Date:  2011-02-12       Impact factor: 2.823

Review 5.  Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.

Authors:  William S Powell; Joshua Rokach
Journal:  Biochim Biophys Acta       Date:  2014-10-29

6.  Regulation of 5-hydroxyeicosanoid dehydrogenase activity in monocytic cells.

Authors:  Karl-Rudolf Erlemann; Chantal Cossette; Gail E Grant; Gue-Jae Lee; Pranav Patel; Joshua Rokach; William S Powell
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

7.  5-Oxo-ETE receptor antagonists.

Authors:  Vivek Gore; Pranav Patel; Chih-Tsung Chang; Sashikala Sivendran; Namin Kang; Yannick P Ouedraogo; Sylvie Gravel; William S Powell; Joshua Rokach
Journal:  J Med Chem       Date:  2013-04-26       Impact factor: 7.446

Review 8.  5-Oxo-ETE and the OXE receptor.

Authors:  Gail E Grant; Joshua Rokach; William S Powell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-05-18       Impact factor: 3.072

9.  Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non-human primates.

Authors:  Lisa A Miller; Chantal Cossette; Shishir Chourey; Qiuji Ye; Chintam Nagendra Reddy; Joshua Rokach; William S Powell
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

Review 10.  A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2021-06-26       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.